MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Low Frequency Directional Deep Brain Stimulation of the Cuneiform Nucleus for Levodopa-Resistant Freezing of Gait: Six-Month Outcomes.

    C. Luca, V. Torres Ballesteros, M. Baumgartner, J. Gujral, L. Qiu, B. Noga, J. Jagid, I. Cajigas (Miami, USA)

    Objective: This is a prospective, open-label, single-arm study to assess safety and efficacy of cuneiform(CnF) deep brain stimulation(DBS) in Parkinson's disease(PD) patients with levodopa-refractory freezing…
  • 2025 International Congress

    Intraoperative deep brain stimulation intrinsic lead migration

    A. Greven, A. Cheung, B. Zavala, F. Ponce (Phoenix, USA)

    Objective: To characterize the intrinsic deep brain stimulation (DBS) lead migration as it relates to different deep brain targets. Background: Effective DBS relies on careful…
  • 2025 International Congress

    Distinguishing DBS and Non-DBS Parkinson’s Patients Using Recurrence Plots and Vision Transformers

    V. Skaramagkas, G. Karamanis, I. Boura, C. Chatzaki, I. Kyprakis, D. Fotiadis, C. Spanaki, Z. Kefalopoulou, M. Tsiknakis (Estavromenos, Heraklion, Greece)

    Objective: To introduce an innovative method for distinguishing gait patterns in Parkinson’s Disease (PD) patients with medical or surgical treatment and healthy controls, by exploiting…
  • 2025 International Congress

    Prodromal Clinical Markers of Parkinson disease in patients with Gaucher disease and their parents

    WZ. Hu, Q. Yang, Y. Huang (Guangzhou, China)

    Objective: To determine the presence of prodromal markers of Parkinson’s disease (PD) in Gaucher disease (GD) patients and their parents. Background: GBA gene mutation is…
  • 2025 International Congress

    The Effects of Non-pharmacological Treatments for Parkinson’s Disease Sleep Disorders:A Systematic Review and Meta-Analysis

    Q. Zhao, Y. Yang, S. Bu, Z. Wang (Shanghai, China)

    Objective: This meta-analysis aimed to assess the clinical efficacy of various non-pharmacological therapies for PD sleep disorders (PDSD) to inform treatment strategies. Background: Sleep disorders…
  • 2025 International Congress

    Sex variations in non-motor symptoms (pain, fatigue, and nausea) in Parkinson’s disease patients: An analysis from the Mexican Parkinson’s Research Network

    A. Solari-Capra, A. Fierro-Ruiz, A. Steven-García, P. Reyes-Pérez, A. Lázaro-Figueroa, E. Morelos-Figaredo, C. Guerra-Galicia, I. Estrada-Bellmann, K. Salinas-Barboza, Y. Matuk-Pérez, N. Gandarilla-Martínez, U. Caballero-Sánchez, P. Montés-Alcántara, V. Flores-Ocampo, I. Espinosa-Méndez, A. Zayas-Del Mora, E. Gaspar-Martínez, E. Waldo, T. Leal, M. Inca-Martinez, I. Mata, S. Alcauter, M. Rentería, A. Medina-Rivera, A. Ruiz-Contreras (Querétaro, Mexico)

    Objective: To compare pain, fatigue and nausea variables between sexes to see if there is a significant difference. Background: Patients with PD present motor and…
  • 2025 International Congress

    Assessment of the Impact of Environmental Factors on Disease Progression in Parkinson’s Disease

    E. Krause, L. Kovalchick, A. Medhus, J. Theo, C. Truong, S. Park, X. Zhang, W. Perkison, T. Krause (Austin, USA)

    Objective: This study evaluated the impact of environmental factors on the progression of Parkinson’s Disease (PD) in Texas using a claims-based algorithm to identify severity…
  • 2025 International Congress

    Seed-based Metabolic Networks and Time Series Variation based on Functional [18F]-FDG PET in Parkinson’s Disease

    M. Ruppert-Junck, V. Heinecke, K. Steidel, L. Rüsing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjürgen, J. Fuchs, H. Müller, M. Luster, L. Timmermann, C. Eggers, D. Pedrosa (Marburg, Germany)

    Objective: To analyse seed-based metabolic networks and time series variation in Parkinson’s disease with and without mild cognitive impairment based on functional PET (fPET) Background:…
  • 2025 International Congress

    Dietary and Environmental Risk factors of Parkinson’s Disease: An integrated study combining Network Pharmacology and Molecular Docking Analyses

    D. Ghosh, P. Basu, S. Mondal, S. Pal (Kolkata, India)

    Objective: This large-scale case-control study using network pharmacology and molecular docking, aimed to identify dietary and environmental risk factors of Parkinson’s disease (PD). Background: PD…
  • 2025 International Congress

    Towards automated deep brain stimulation programming using neurophysiology and artificial intelligence

    V. Lavu, J. Cagle, T. de Araujo, K. Johnson, C. de Hemptinne, J. Wong (Gainesville, USA)

    Objective: To develop a machine learning (ML) algorithm capable of predicting the optimal deep brain stimulation (DBS) contact based on neurophysiology. Background: DBS is an…
  • « Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley